Zur Rose Group AG (OTCMKTS:ZRSEF) Given Consensus Rating of “Hold” by Analysts

Shares of Zur Rose Group AG (OTCMKTS:ZRSEF – Get Rating) have earned a consensus recommendation of “Hold” from the ten research firms that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $72.40.

A number of research analysts have recently issued reports on ZRSEF shares. Jefferies Financial Group raised Zur Rose Group from a “hold” rating to a “buy” rating in a research note on Monday, February 6th. Citigroup raised Zur Rose Group from a “sell” rating to a “neutral” rating in a research note on Monday, February 6th. Finally, Deutsche Bank Aktiengesellschaft raised Zur Rose Group from a “sell” rating to a “hold” rating in a research note on Monday, February 6th.

Zur Rose Group Price Performance

Shares of OTCMKTS:ZRSEF opened at $53.37 on Tuesday. The business’s 50-day moving average is $37.59 and its 200-day moving average is $36.48. Zur Rose Group has a 1 year low of $23.64 and a 1 year high of $185.00.

Zur Rose Group Company Profile

(Get Rating)

Zur Rose Group AG engages in the operation of an e-commerce pharmacy and the wholesale of medical and pharmaceutical products. It operates through the following geograpical segments: Switzerland, Germany, and Europe. The company was founded by Walter Oberhänsli on April 6, 1993 and is headquartered in Frauenfeld, Switzerland.